Hirayama; Yoshiaki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hirayama; Yoshiaki.The latest application filed is for "utilization of cilastatin in inhibiting renal disorder".

Company Profile

2.12.15

Hirayama; Yoshiaki - Tokyo JP
Hirayama; Yoshiaki - Gosen JP
HIRAYAMA; Yoshiaki - Gosen-shi JP
HIRAYAMA; Yoshiaki - Niigata JP
HIRAYAMA; Yoshiaki - Kigoshi Gosen-shi

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Utilization of cilastatin in inhibiting renal disorder Grant 11,304,919 - Saito , et al. April 19, 2	2022-04-19
Utilization Of Cilastatin In Inhibiting Renal Disorder App 20210228522 - SAITO; Akihiko ; et al.	2021-07-29
Method for estimating number of podocytes in urine Grant 10,809,265 - Hara , et al. October 20, 2	2020-10-20
Sample extraction kit and sample extraction method Grant 10,422,728 - Suzaki , et al. Sept	2019-09-24
Method For Estimating Number Of Podocytes In Urine App 20180120324 - Hara; Masanori ; et al.	2018-05-03
Sample Extraction Kit And Sample Extraction Method App 20170315028 - SUZAKI; Masashi ; et al.	2017-11-02
Test Method On Renal Diseases App 20170146553 - HARA; Masanori ; et al.	2017-05-25
Method For Test On Diabetic Nephropathy App 20170146554 - HARA; Masanori ; et al.	2017-05-25
Method For Increasing The Sensitivity Of Immunoassay System Through Pretreatment Of Urine With Denaturant App 20170108490 - Kurosawa; Hiroyuki ; et al.	2017-04-20
Method for estimating GFR (glomerular filtration rate) from measured value of megalin in urine Grant 9,625,452 - Yamagata , et al. April 18, 2	2017-04-18
Method for increasing the sensitivity of immunoassay system through pretreatment of urine with denaturant Grant 9,568,470 - Kurosawa , et al. February 14, 2	2017-02-14
Method For Detecting Podocytes In Urine App 20160003820 - HARA; Masanori ; et al.	2016-01-07
A Method For Estimating Gfr (glomerular Filtration Rate) From Measured Value Of Megalin In Urine App 20160003810 - YAMAGATA; Kunihiro ; et al.	2016-01-07
Method For Increasing The Sensitivity Of Immunoassay System Through Pretreatment Of Urine With Denaturant App 20150285791 - Kurosawa; Hiroyuki ; et al.	2015-10-08
Method for examining acute renal disorder Grant 8,673,577 - Hara , et al. March 18, 2	2014-03-18
Method for detecting renal disease comprising measuring human megalin in urine Grant 8,663,931 - Saito , et al. March 4, 2	2014-03-04
Use of megalin in urine as marker for detecting renal disorder Grant 8,628,930 - Saito , et al. January 14, 2	2014-01-14
Method For Examining Acute Renal Disorder App 20120322087 - Hara; Masanori ; et al.	2012-12-20
Method For Test On Diabetic Nephropathy App 20120164667 - Hara; Masanori ; et al.	2012-06-28
Test Method On Renal Diseases App 20120164662 - Hara; Masanori ; et al.	2012-06-28
Use Of Megalin In Urine As Marker For Detecting Renal Disorder App 20120058489 - Saito; Akihiko ; et al.	2012-03-08
Method For Detecting Renal Disease Comprising Measuring Human Megalin In Urine App 20120040374 - Saito; Akihiko ; et al.	2012-02-16
Urine pretreatment agent for urinary protein quantitation, urine pretreatment method, and urinary protein quantitation method Grant 8,105,840 - Hara , et al. January 31, 2	2012-01-31
Urine Pretreatment Agent For Urinary Protein Quantitation, Urine Pretreatment Method, And Urinary Protein Quantitation Method App 20100233738 - Hara; Masanori ; et al.	2010-09-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.